Clinical trial
SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best…
NCT00259792 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00259792 |
|---|---|
| Title | SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults |
| Official title | A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26-week, Randomised, Open, Parallel Group Multicentre Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/formoterol Turbuhaler |
| Enrollment | 1,000 |
| Start date | Sep 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: